@FWCStocks Avatar @FWCStocks FWCStocks

FWCStocks posts on X about $vera, $goss, $tecx, $vtyx the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

Engagements: [---] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [---] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 47.27% finance 25.45% countries 8.18% currencies 5.45% financial services 2.73% cryptocurrencies 0.91% nfl 0.91% technology brands 0.91% fashion brands 0.91%

Social topic influence $vera 17.27%, $goss #6, $tecx #2, $vtyx 8.18%, $cccc 6.36%, target 6.36%, $clym 5.45%, $annx 5.45%, in the 5.45%, $pali 5.45%

Top accounts mentioned or mentioned by @semodough @biotech2k1 @doepkemichel @bosstrading0 @amaymd @avidresearch @seedy19tron @pawcio2009 @geneinvesting @andreagtc @monacobiotech @jfais20 @chartsrus0 @rnaianalyst @diamondguyizzy @albrtspain @stocksavvyshay @tradeacct17 @biostocks @pharmdca

Top assets mentioned Vera Therapeutics, Inc. (VERA) Ventyx Biosciences, Inc. (VTYX) C4 Therapeutics, Inc (CCCC) Climb Bio, Inc (CLYM) Annexon, Inc. (ANNX) Kyverna Therapeutics, Inc. (KYTX) Wave Life Sciences Ltd. Ordinary Shares (WVE) Synthetify (SNY) Eli Lilly and Company (LLY) BlackRock Inc (BLK) Xilio Therapeutics, Inc. (XLO) Morgan Stanley (MS) GSK plc (GSK) Legend Biotech Corp (LEGN) AstraZeneca PLC (AZN) Consolidated Edison, Inc. (ED) Travere Therapeutics, Inc. Common Stock (TVTX) Sarepta Therapeutics, Inc. (SRPT) uniQure N.V. (QURE) Goldman Sachs (GS)

Top Social Posts

Top posts by engagements in the last [--] hours

"Money flowing in from AI/Tech to Biotech which is why the XBI is not falling like other indexes. Biotech will rebound very soon. $KYTX Started a large position on the stupid selloff. $CCCC: Added shares $STRO: Added shares $ACET: Added shares $WVE: Added/Doubled my Shares"
X Link 2025-12-17T22:03Z [---] followers, [---] engagements

"Been taking advantage of some year-end profit-taking (selling) to add to a few of my positions with $CCCC $CLYM $TECX $VERA and $GOSS. Fully expecting biotech stocks to come roaring back after January 1"
X Link 2025-12-30T16:23Z [---] followers, [---] engagements

"@Biotech2k1 $TECX $ANNX"
X Link 2026-01-07T01:18Z [---] followers, [---] engagements

"$VERA Highlights from #JPM26. (part 1) -PDUFA date 7/7/26. Priority review awarded. -Investigating atacicept in [--] other diseases -1st Dual BAFF/APRIL inhibitor. -Drug stopped Kidney Function/EGFR Slope decline. -Sales Leadership in place. Now hiring [--] sales reps"
X Link 2026-01-13T22:56Z [---] followers, [---] engagements

"$CCCC: By year-end 2026: -Earn research milestones/licensing fees from collaborations with Merck KGaA Darmstadt Germany Roche and Biogen. -Deliver at least one development candidate to a collaboration partner. -Advance existing collaborations toward key milestones"
X Link 2026-01-14T12:55Z [---] followers, [---] engagements

"@Andre_AGTC $VERA is down about 15% in the past month. Great time to add to positions with a PDUFA by July. Most financial firms have Price Targets of $75-$100+/share. With $VERA already looking at other targets for their drug FDA approval is highly likely and it is a buyout target"
X Link 2026-01-20T16:59Z [---] followers, [---] engagements

"$VERA is down about 15% in the past month. Great time to add to positions with a PDUFA by July. Most financial firms have Price Targets of $75-$100+/share. With $VERA already looking at other targets for their drug FDA approval is highly likely and it is a buyout target"
X Link 2026-01-20T17:00Z [---] followers, [---] engagements

"$ANNX: New 52-Week High. +11% so far today on no news"
X Link 2026-01-21T20:51Z [---] followers, [---] engagements

"$VERA announces Chief Commercial Officer. $VERA is a strong buy at current levels ($47) with an Accelerated Approval PDUFA date of July [--]. This one will hit Cantor: $100 Evercore: $97 JPM: $95 Goldman: $95 HC Wainright: $90 https://finance.yahoo.com/news/vera-therapeutics-announces-appointment-matt-123000128.html https://finance.yahoo.com/news/vera-therapeutics-announces-appointment-matt-123000128.html"
X Link 2026-01-28T13:30Z [---] followers, [---] engagements

"$VERA Highlights from #JPM26. -Announced Chief Commercial Officer on 1/28/26. -Now hiring [--] sales reps. -Accelerated Approval. PDUFA date 7/7/26. -1st Dual BAFF/APRIL inhibitor. -Stopped EGFR Slope decline. -Investigating atacicept in [--] other diseases"
X Link 2026-01-28T13:34Z [---] followers, [---] engagements

"Pretty telling sign that a positive catalyst that will skyrocket the share price of $GOSS and cause a huge short squeezeis only days away"
X Link 2026-01-30T04:02Z [---] followers, [----] engagements

"Great opportunity to grab very cheap shares of $VERA prior to approval of Atacicept for IGaN with a July [--] PDUDA. I see $VERA as a good M&A target. VERA usually trades around $48-52/share and should begin to run up soon. Numerous PTs in the $75-$100 range"
X Link 2026-02-01T07:40Z [---] followers, [--] engagements

"$KYTX flying under the radar and a good time to accumulate shares. Leerink Wells Fargo Morgan Stanley all with a 200-300% return forecasted from here. Cash runway into [----] is expected to fully fund SPS BLA filing 1H26 with commercial launch and a Phase [--] gMG trial"
X Link 2026-02-01T07:56Z [---] followers, [---] engagements

"@A_May_MD Overall while the read-through validates concerns about relaxin-class efficacy (LLY AZD3427s inefficacy) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"
X Link 2026-02-10T11:47Z [---] followers, [---] engagements

"@A_May_MD I be doing some additional research to see if I will double down and purchase more shares on this selloff. But I will not be selling shares today and wouldnt be surprised at all if we see some buying on the dip"
X Link 2026-02-10T11:49Z [---] followers, [---] engagements

"@monaco_biotech Not selling May be buying more shares today"
X Link 2026-02-10T11:52Z [---] followers, [--] engagements

"$ANNX is Wells Fargo's #2 TOP PICK in SMID Cap Biotech behind $ARGX. Wells Fargo: We believe the [----] setup offers a significant asymmetric risk/reward with Venture Capital-like returns of more than 10x in the NTM. We expect shares to run up ahead of 2H data"
X Link 2026-01-09T04:45Z [---] followers, [---] engagements

"@jfais20 I'm focusing on clinical/pre-clinical stage biotechs that have catalysts this year or next. These companies will move the needle one way or the other. Up 75% overall since June '25. $ANNX $CCCC $CLYM $GOSS $KYTX $PALI $STRO $TECX $VERA. That's all of them for right now"
X Link 2026-01-14T01:38Z [---] followers, [---] engagements

"2026: I'm ONLY focusing on clinical stage biotechs that have catalysts in [----]. I think these companies will move the needle nicely. 85% return overall since June '25. My current slate: $ANNX $CCCC $CLYM $GOSS $KYTX $PALI $STRO $TECX $VERA. Sold $VTYX"
X Link 2026-01-14T01:45Z [---] followers, [---] engagements

"So basically $SNY blew their opportunity to acquire $VTYX. Fantastic reporting by UBS here. My repost comes in multiple comments. Proxy filing for the proposed acquisition of VTYX by LLY reveals that (1) SNY declined to exercise its ROFN on VTYX's VTX3232 and"
X Link 2026-01-25T18:24Z [---] followers, [---] engagements

"Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"
X Link 2026-02-02T16:22Z [---] followers, 12.8K engagements

"$TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"
X Link 2026-02-03T15:29Z [---] followers, [---] engagements

"$WVE: Listening to the Cantor Fitzgerald webinar with $WVE management. WV-007 data coming up is very impressive and they're excited. Confirmed it will be in Q1 [----]. -Great differentiated data. -Accelerating higher BMI fully enrolled study w/ [---] patients"
X Link 2026-02-04T18:35Z [---] followers, [---] engagements

"$WVE: Part [--] Cantor webinar. -WVE-007: Exploring strategic collaborations. -WVE-006: CEO confirmed $GSK did NOT see new data before giving full rights to $WVE. GSK continues to support $WVE. -INHBE may be studied in other therapeutic treatments like MASH"
X Link 2026-02-04T19:03Z [---] followers, [---] engagements

"$GOSS Part [--]. H.C. Wainwright (Buy $10 PT) Barclays (Overweight $9) Cantor Fitzgerald (Overweight) Piper Sandler (Buy $15) Oppenheimer ($12) PROSERA data (Feb 2026) could drive 3-5x upside if positive; M&A speculation high given management track record and PAH market ($6B+)"
X Link 2026-02-07T21:22Z [---] followers, [---] engagements

"$GOSS Institutions/Hedge funds: Octagon Capital: 7.4% (16.7M shares). New Enterprise: 7.8% (17.6M shares). BlackRock: 6.0% (13.5M shares). Perceptive Advisors: 3.8M shares (2%). Rock Springs Capital: 3.3M shares (1.7%). Total funds/institutions: [---] (up 14% QoQ)"
X Link 2026-02-07T21:26Z [---] followers, [---] engagements

"$GOSS: Seralutinib demonstrates in vitro reduction of vascular inflammatory drivers underlying pulmonary hypertension. Zhaoqing Ding Elisa Schiavi Silvia Cantoni European Respiratory Journal [----] 66(suppl 69): PA1039"
X Link 2026-02-07T21:52Z [---] followers, [----] engagements

"$LEGN ($17/sh): Partnership with JNJ. Consistent durable efficacy and particularly compelling outcomes for Carvykti when used in patients' multiple myeloma treatment journey. PTs: Barclays ($80) HCW ($50) Cowan ($26) Oppenheimer ($75) MS:($50). s https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings https://investors.legendbiotech.com/news-releases/news-release-details/legend-biotech-present-carvyktir-data-2026-tandem-meetings"
X Link 2026-02-09T02:19Z [---] followers, [---] engagements

"$AZN financials and pipeline update on February [--]. $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready $TECX: No one is selling. Wells Fargo expected a 25%+ run in share price AFTER positive AZN3427 news. It hasn't even been released yet and we're up almost 30% in [--] days. Wells previously noted in their research that there's a very large short interest in $TECX. Get ready"
X Link 2026-02-09T02:23Z [---] followers, [---] engagements

"$TECX: While the read-through validates concerns about relaxin-class efficacy (LLY AZD3427) TX45s design dosing and targeted approach offer a plausible path to success potentially viewing the market dip as an overreaction similar to post-Lilly events"
X Link 2026-02-10T11:50Z [---] followers, [---] engagements

"Wells Fargo note this morning says the pullback $TECX is overdone since we dont know details and the TX-45 trial could be differentiated. AZN news still a concern. Wells Fargo views the magnitude of the pullback as if the TX-45 trial itself failed. Maintains a $101 Price Target"
X Link 2026-02-10T15:23Z [---] followers, [---] engagements

"$TECX. Recall IF the Phase [--] TX45 readout this year is positive Wells Fargo expects a 5-10x run in share price. This was based on research in November. With AZN competition out of the way its hard not to consider loading up shares at these levels for an insane 10x+ return"
X Link 2026-02-10T15:54Z [---] followers, [---] engagements

"Even the CFO of $TECX took advantage of the panic selloff. Big things coming for $TECX soon for [--] different indications. If Prosera trial readout is positive Wells Fargo expects a 6-10x rise in share price (Price Target $101). $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved Ejection Fraction (HFpEF) Phase [--] Group [--] Pulmonary Hypertension https://t.co/L4MXW6iXPs $TECX CFO acquires $120k at open market $XBI $IBB Catalyst/readout [----] Phase [--] RXFP1 Agonist (TX45 Fc-relaxin) Heart Failure with Preserved"
X Link 2026-02-12T08:23Z [---] followers, [---] engagements

"$VERA's upcoming FDA Approval/commercial launch will lead to much higher sales than the street is expecting. Otsuka revenue forecast this AM is 2x expectations. $VERA is an APRIL/BAFF inhibitor with superior EGFR data (Otsuka targets only BAFF). $VERA is a STRONG BUY. PT $70-$100"
X Link 2026-02-13T13:24Z [---] followers, [---] engagements

"RT @semodough: $GOSS @avidresearch am I reading that right BLACKROCK added [--] million as yesterday bringing there total to [--] million $GOS"
X Link 2026-02-13T15:26Z [---] followers, [--] engagements

"Theres a lot of short-selling occurring with $GOSS prior to an enormous binary event/readout in the next couple of weeks. I suspect well see a wave of buying begin soon. Many positive research reports support a positive readout with much higher results any Price Targets"
X Link 2026-02-07T04:37Z [---] followers, [----] engagements

"$TECX: Management buy $175000 of stock on the open market"
X Link 2026-02-15T09:02Z [---] followers, [--] engagements

"$VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:46Z [---] followers, [--] engagements

"@doepke_michel $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:47Z [---] followers, [---] engagements

"@BOSSTRADING0 @ChartsRUs0 $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:48Z [---] followers, [---] engagements

"@RNAiAnalyst $VTYX: I'm not convinced there won't be a bidding war $SNY has the Right of First Refusal yet reports say $LLY is the poss. acquirer. Doesn't make complete sense why $SNY would drop it. The $14 rumored price may be too low. Keep in mind: Wells Fargo PT is $25 and UBS PT is $20"
X Link 2026-01-07T17:49Z [---] followers, [---] engagements

"Struggling with $ED Theres no pill to tell you when to buy or sell. 😂😂😂"
X Link 2026-01-09T01:15Z [---] followers, [--] engagements

"@Biotech2k1 Youre the only one who posts daily about how you want to sell and that theres a biotech bubble. I see this from nobody else and instead theses and risk are based on expected growth and development of their products"
X Link 2026-01-12T13:59Z [---] followers, [---] engagements

"The $VERA PDUFA will be close to the new PDUFA date for $TVTX. $VERA presents this afternoon at #JPM. $VERA has a very high likelihood of approval is a much better company to own and share price should at least double (see numerous Price Targets) leading up to/after approval"
X Link 2026-01-13T19:00Z [---] followers, [---] engagements

"-Sales reps initially targeting [----] nephrologists. -More results later this year about targeting other autoimmune diseases. -More trial data coming at ERA in June. -$779M in cash. $425M additional non-dilutive avail"
X Link 2026-01-13T22:59Z [---] followers, [--] engagements

"@BOSSTRADING0 UBS upgraded $GOSS to Buy with a price target of $9. Views the risk/reward as "compelling" into the Ph [--] pulmonary arterial hypertension data in February [----]. Probability of success is underappreciated and seralutinib offers a "differentiated" mechanism of action"
X Link 2026-01-14T03:19Z [---] followers, [---] engagements

"@doepke_michel Interesting by year-end 2026: -Earn research milestones/licensing fees from collaborations with Merck KGaA Darmstadt Germany Roche and Biogen. -Deliver at least one development candidate to a collaboration partner. -Advance existing collaborations toward key milestones"
X Link 2026-01-14T12:55Z [---] followers, [--] engagements

"$PALI: Buying the selloff. 1) Phase 1b data for PALI-2108 in fibrostenotic Crohn's disease (FSCD) expected in (Q1 2026). Topline safety pharmacokinetics (PK) and pharmacodynamics (PD) data. 2) The Crohn's & Colitis Foundation just made a $500000 investment in $PALI"
X Link 2026-01-16T16:34Z [---] followers, [----] engagements

"@diamondguyizzy There was a run-up and peak at the end of December when they were granted a patent by Japan for PALI-2108. I think this one is under the radar. Hence why I am slowly building my position"
X Link 2026-01-16T16:39Z [---] followers, [---] engagements

"$PALI today announced that two abstracts highlighting its lead program PALI-2108 have been selected for presentation at two premier international inflammatory bowel disease (IBD) meetings in early 2026"
X Link 2026-01-16T16:44Z [---] followers, [---] engagements

"@Albrtspain Piper Sandler initiated coverage of $PALI with an Overweight rating and $25 price target. Piper says Palisade "is a great name to own" ahead of PALI-2108's Phase1b fibrostenotic Crohn's disease data in Q1. The shares are undervalued considering that PDE4 inhibition is validated"
X Link 2026-01-17T04:27Z [---] followers, [---] engagements

"@pawcio2009 Next up $PALI. +12% pop today on no news"
X Link 2026-01-20T21:13Z [---] followers, [---] engagements

"Nothing says upcoming failed drug trial like a press release at [--] pm on a Friday announcing upcoming results on Monday Okay okay well see but just wondering. $SRPT"
X Link 2026-01-23T23:13Z [---] followers, [---] engagements

"(2) LLY was ultimately the only bidder on VTYX despite SNY and another large pharma company conducting advanced due diligence although negotiations with LLY coincided with holiday recesses for SNY and Party A"
X Link 2026-01-25T18:25Z [---] followers, [--] engagements

"Recall in Sep [----] SNY invested $27M into VTYX and received a right of first negotiation (ROFN) on VTYX's CNS-penetrant NLRP3 inhibitor VTX3232. The negotiation period of the ROFN was to open after VTYX shared obesity data for '3232 in Oct 2025"
X Link 2026-01-25T18:25Z [---] followers, [--] engagements

"VTYX contacted [--] biopharmaceutical companies (including LLY and SNY). Of these [--] did not express interest [--] expressed interest in a license of '3232 for neurological indications alone [--] conducted preliminary due diligence but did not pursue"
X Link 2026-01-25T18:25Z [---] followers, [--] engagements

"2 conducted initial due diligence but required additional clinical data and three (LLY SNY and another large pharma company referred to as Party A) entered advanced due diligence"
X Link 2026-01-25T18:26Z [---] followers, [--] engagements

"VTYX representatives contacted Party A on Dec [--] and SNY on Dec [--] to inform them VTYX had received an acquisition proposal. Party A stated their due diligence was ongoing and they were unlikely to accelerate any deliberations over the holidays"
X Link 2026-01-25T18:26Z [---] followers, [--] engagements

"The representative of VTYX did not respond due to the ongoing exclusivity agreement. On Jan [--] VTYX and LLY signed and announced the merger agreement"
X Link 2026-01-25T18:27Z [---] followers, [--] engagements

"President Trump calls #HURRICANE Irma some big monster #FWCWeather http://gpwx.news/0rmwv http://gpwx.news/0rmwv"
X Link 2017-09-11T00:46Z [---] followers, [--] engagements

"$XLO: You might want to look at this one -$17.5M milestone achieved with Gilead -Abbvie and Xilio Collab: Xilio receives $52.0M in upfront payments $10.0M equity investment. Eligible for $2.1B in fees milestones royalties. @StockSavvyShay https://finance.yahoo.com/news/xilio-therapeutics-announces-upcoming-presentations-130000244.html https://finance.yahoo.com/news/xilio-therapeutics-announces-upcoming-presentations-130000244.html"
X Link 2025-10-07T14:20Z [---] followers, [---] engagements

"@pawcio2009 @seedy19tron @A_May_MD @trade_acct_17 Others to watch these week: $CLYM $XLO $QURE $VTYX"
X Link 2025-11-02T12:06Z [---] followers, [---] engagements

"$VERA +13% today going +100-200% next few months. VERY confident. Jim Meyers former E.V.P of Gilead named to VERA's Board of Directors today. VERA submitted BLA with Accelerated Approval to FDA. [--] conferences next week. @seedy19tron @BioStocks @Pharmdca https://finance.yahoo.com/news/vera-therapeutics-appoints-veteran-biotech-210500545.html https://finance.yahoo.com/news/vera-therapeutics-appoints-veteran-biotech-210500545.html"
X Link 2025-11-26T23:19Z [---] followers, [--] engagements

"$VERA Presents on 12/2/25 at the Evercore Healthcare Conference. $CLYM Presents on 12/2/25 at the Piper Sandler Healthcare Conference. $CCCC Presents on 12/3/25 at the Evercore Healthcare Conference. $VERA Presents on 12/3/25 at the Citi Healthcare Conference"
X Link 2025-12-02T00:09Z [---] followers, [---] engagements

"$VERA: All-time high of $51.72 reached today on the heals of several analyst upgrades this morning. JP Morgan: Upgrade to $96/share Goldman Sachs: Upgrade to $95/share BofA: Upgrade to $66/share Numerous other upgrades in the past few weeks with PT's generally $80-$100/share"
X Link 2025-12-19T18:28Z [---] followers, [---] engagements

"$KYTX: A Director and a fund buy over [------] shares of the stock on the open market a few days ago. Very bullish"
X Link 2025-12-23T11:20Z [---] followers, [---] engagements

"@doepke_michel No mention of $VERA $VTYX or $WVE Most of these are on my list with much higher probabilities of acquisition than the ones you list here IMO"
X Link 2025-12-28T19:16Z [---] followers, [----] engagements

"@BOSSTRADING0 $VERA $TECX $STRO and $CLYM"
X Link 2026-01-02T01:17Z [---] followers, [---] engagements

"@doepke_michel $VERA"
X Link 2026-01-02T22:57Z [---] followers, [---] engagements

"@Biotenic @Biotenic the $VERA PDUFA is expected around July or so"
X Link 2026-01-05T01:34Z [---] followers, [---] engagements

"$VTYX halted $LLY in advanced talks to buy Ventyx Biosciences in more than $1 billion deal WSJ reports"
X Link 2026-01-06T20:58Z [---] followers, [---] engagements

"$ANNX: +14% today so far"
X Link 2026-01-13T19:52Z [---] followers, [--] engagements

"$CCCC: +10% today so far"
X Link 2026-01-13T19:54Z [---] followers, [--] engagements

"You should check out this presentation when it's posted @Biotech2k1 @BOSSTRADING0 @semodough. $VERA may be targeting [--] other indications in autoimmune diseases. This one is for the long haul"
X Link 2026-01-13T23:05Z [---] followers, [---] engagements

"$BIIB: Regarding BD management noted interest in "one more near-term growth asset something end of Phase III/early commercial" and a continued commitment to rare immunology. @JPM26:"
X Link 2026-01-14T00:07Z [---] followers, [---] engagements

"@PikaBulb @GeneInvesting Seems like the selloff in advance of the $GOSS February Phase [--] Readout will follow suit with a huge run. Current Price: $2.55 Price Targets Oppenheimer: $12 Cantor: Strong Buy UBS: $9 Scotia Bank: $11"
X Link 2026-01-27T16:22Z [---] followers, [---] engagements

"Tee Up $GOSS: Seems like the selloff in advance of the February Phase [--] Readout will follow suit with a huge run. Current Price: $2.55 Price Targets: Oppenheimer: $12 UBS: $9 Scotia Bank: $11 Cantor: Strong Buy"
X Link 2026-01-27T16:24Z [---] followers, [---] engagements

"@GeneInvesting @Biotech2k1 I have no skin in the game for $NTLA but interesting that Wells Fargo has a PT of $12. The share price action today on this news is not encouraging"
X Link 2026-01-28T02:21Z [---] followers, [---] engagements

"@semodough This is the one to watch in the VERY near term. Huge short interest high PTs from the analysts and a big catalyst coming possibly in days"
X Link 2026-01-28T03:11Z [---] followers, [--] engagements

"$GOSS: Gossamer Bio files automatic mixed securities shelf. I view this as very POSITIVE considering they have a very important Phase [--] readout days away. We usually see money being raised after a big rally on really good news. THIS IS A SIGN THE READOUT WILL BE VERY POSITIVE"
X Link 2026-01-28T21:13Z [---] followers, [----] engagements

"@avidresearch Pretty telling sign that a positive catalyst that will skyrocket the share price of $GOSS and cause a huge short squeezeis only days away"
X Link 2026-01-30T04:02Z [---] followers, [---] engagements

"Think well see more dough @semodough This is a pretty informative clue"
X Link 2026-01-30T04:12Z [---] followers, [---] engagements

"@seedy19tron Just doubled my position in $GOSS. Disagree with your short position but we shall see. The research from Barclay's (1/27 with a $9 PT) HC Wainwright (1/22 with a $10 PT) and Piper Sandler (1/12 with a $15 PT) are all very supportive of a positive readout and quite compelling"
X Link 2026-01-30T19:30Z [---] followers, [----] engagements

"$TECX: Up 15% so far today. Sleeping giant - A lot of big things in the pipeline. Price Targets: $60: Truist $80: Oppenheimer $101: Well Fargo $76: Raymond James $88: LifeSci Capital $85: Mizuho"
X Link 2026-02-02T15:35Z [---] followers, [---] engagements

"@semodough Thank you. Huge for $TECX No one knows about this March [----] article yet. Proves $LLY's trial failure was a one-off & validates $TECX. Wells Fargo: Shares go 25%+ on a positive AZN readout & 5-10x on a positive Phase [--] TX45 readout. Hold on tight https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1 https://www.cell.com/molecular-therapy-family/advances/fulltext/S3117-387X(26)00009-1"
X Link 2026-02-02T16:21Z [---] followers, [---] engagements

"@avidresearch Good point and agree. I'm only pointing out what Wells Fargo said. I think it would fly 50-100% higher from current levels"
X Link 2026-02-02T20:30Z [---] followers, [---] engagements

"Supplies for #HURRICANE victims stolen from church #FWCWeather http://gpwx.news/wxh6e http://gpwx.news/wxh6e"
X Link 2017-09-11T22:45Z [---] followers, [--] engagements

"Texas company builds new oyster reef after #HURRICANE Harvey devastated population #FWCWeather http://gpwx.news/beqc1 http://gpwx.news/beqc1"
X Link 2018-07-16T23:00Z [---] followers, [--] engagements

"Magnitude [---] #EARTHQUAKE strikes Indonesia prompting #TSUNAMI warning #FWCWeather http://gpwx.news/6529g http://gpwx.news/6529g"
X Link 2018-08-05T13:15Z [---] followers, [--] engagements

"More People See Climate Change In Record Floods And Extreme #WEATHER. Will That Mean More Action #FWCWeather http://gpwx.news/8317k http://gpwx.news/8317k"
X Link 2019-06-08T10:19Z [---] followers, [--] engagements

"Keeping it real with a tough forecast NWS Nashville [---] PM CDT Jul [--] [----] I dont usually do this but Ive sat here for [--] minutes trying to decide what to type. My struggles revolve around the lack of any consistency between models when it comes to storm development 1/2"
X Link 2023-07-18T08:29Z [---] followers, [---] engagements

"Daily dose of weather humor: Tornado report near the Charleston SC area. According to the NWS video was used to confirm that the car was hi"
X Link 2023-08-31T06:02Z [---] followers, [---] engagements

"@hurricanetrack The Euro did terribly early on with Idalia. I see a slightly stronger ridge and slightly weaker Great Lakes trough in some of the latest models. Will be interesting to see if that trend (and a further west track) occurs. NOAA Recon and additional soundings start tomorrow"
X Link 2023-09-07T01:02Z [---] followers, [---] engagements

"Happy 1st Day of School This cloud-to-ground (CG) lightning bolt struck this tree (I took pictures of both) that landed on Guilderland High School in New York causing minor damage. A microburst with 50-60 mph winds and nickel sized hail also occurred"
X Link 2023-09-07T22:48Z [---] followers, [---] engagements

"Amazing photograph of the northern lights at the National Weather Service in Riverton Wyoming this morning. Its going to be an exciting [--] hours in the northern US and Canada for aurora borealis. Photo: NWS Riverton"
X Link 2023-11-05T12:47Z [---] followers, [---] engagements

"@Giants New York Giants New Years resolution: Learn how to tackle. Pathetic"
X Link 2023-12-26T00:16Z [---] followers, [--] engagements

"Not too often do you see a Severe Thunderstorm Warning in Puerto Rico. TJUA - Super-Res Reflectivity [--] 6:39 PM Super-Res Velocity [--] 6:34 PM #prwx"
X Link 2024-05-02T22:41Z [---] followers, [--] engagements

"Looks like an enormous tornado over Robert Lee (apparently a town in Texas). Just the good ole boys never meaning no harm.beats all the standing corn and causes trouble with the law since the minute it formed. KSJT - Super-Res Reflectivity [--] 5:37 PM Super-Res Velocity 1"
X Link 2024-05-03T21:39Z [---] followers, [---] engagements

"Heavy damage from Hurricane Beryl on the beautiful Caribbean island of Martinique. https://youtu.be/UHEK-4FWXzssi=_ZPdi5hjGZPCaSp2 https://youtu.be/UHEK-4FWXzssi=_ZPdi5hjGZPCaSp2"
X Link 2024-07-03T01:54Z [---] followers, [---] engagements

"@RLazear @btangyWx Funny. I was a couple of towns over in Waterville and took these. Im going to be processing a time lapse I took of the supercell with my GoPro"
X Link 2024-07-11T02:37Z [---] followers, [---] engagements

"G75 MPH on the OHare ASOS. WOW. Going to be a lot of flight delays and cancellations overnight KORD 160251Z 32024G50KT [--] 1/2SM R10L/3500VP6000FT +TSRA BR SQ BKN019CB BKN040 OVC140 22/21 A2972 RMK AO2 PK WND 26065/0239 RAB38 TSB26 PRESRR SLP060 CONS LTGCGIC OHD"
X Link 2024-07-16T03:03Z [---] followers, [---] engagements

"This week we had the opportunity of a lifetime to take a private tour of The White House. We arrived for our tour a few hours after President Biden arrived at the White House and the same day that Prime Minister Netanyahu arrived in Washington. What an experience"
X Link 2024-07-27T14:29Z [---] followers, [--] engagements

"Secret Service cleared the rest of our photos. Heres one from the Rose Garden at The White House. Biden was in his residence behind that far door. What an epic visit"
X Link 2024-08-06T03:02Z [---] followers, [--] engagements

"@POTUS Waityoure actually not on vacation and AT The White House"
X Link 2024-09-11T03:22Z [---] followers, [--] engagements

"Hey @MTV : Completely tasteless that MTV has their VMAs tonight and so many celebs celebrate. Red carpet After parties Who the F cares what youre wearing. On 9/11 Disgraceful"
X Link 2024-09-12T01:14Z [---] followers, [---] engagements

"BREAKING NEWS: Magnitude [---] earthquake just hit the Cayman Islands. Tsunami warning going up for most of the Caribbean Islands. Not sure about FL or the gulf coast yet. https://earthquake.usgs.gov/earthquakes/eventpage/us7000pcdl/executiveutm_medium=email&utm_source=ENS&utm_campaign=realtime https://earthquake.usgs.gov/earthquakes/eventpage/us7000pcdl/executiveutm_medium=email&utm_source=ENS&utm_campaign=realtime"
X Link 2025-02-08T23:54Z [---] followers, [---] engagements

"@GenFlynn Take a deep breath General. Not everything needs to be a conspiracy theory or extravagant unsupported assumptions. Its hot and very humid in Texas. When rare conditions like this align just right which was the case here you get terrible flash flooding. So sad"
X Link 2025-07-06T16:58Z [---] followers, [---] engagements

"#HURRICANE Ophelia now a major storm barreling toward Ireland #FWCWeather http://gpwx.news/5138k http://gpwx.news/5138k"
X Link 2017-10-14T16:29Z [---] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing